Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 303 $ 203
Operating costs and expenses:    
Research and development 1,551 820
Selling, general and administrative 2,763 1,214
Merger related costs 2,145
Total operating costs and expenses 4,700 4,639
Loss from operations (4,397) (4,436)
Other (expense) income:    
Change in fair value of warrant liability 214
Change in fair value of share-settlement obligation derivative (250)
Loss on debt conversions (2,518)
Interest expense (9) (368)
Total other expense (9) (2,922)
Loss from continuing operations before income taxes (4,406) (7,358)
Income tax expense (benefit)
Loss from continuing operations (4,406) (7,358)
Discontinuing operations (net of $0 tax benefit in 2022 and 2021) (4,757) (8)
Net loss (9,163) (7,366)
Cumulative translation adjustment 4
Comprehensive loss $ (9,159) $ (7,366)
Net loss per share attributed to common stock – basic and diluted:    
Net loss per share from continuing operations $ (0.15) $ (2.31)
Net loss per share from discontinuing operations (0.17)
Net loss per share $ (0.32) $ (2.31)
Weighted average shares outstanding:    
Weighted average common shares outstanding - Basic and Diluted 29,012,536 3,184,106
Service [Member]    
Revenue:    
Total revenue $ 94 $ 97
Operating costs and expenses:    
Cost of goods sold 38 64
Product [Member]    
Revenue:    
Total revenue 209 106
Operating costs and expenses:    
Cost of goods sold $ 348 $ 396